Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tirzepatide users experience more hair loss than semaglutide users.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Ruxolitinib cream may help treat severe hair loss in children.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Minoxidil and tretinoin together may help hair growth but need more research.

Bupropion SR may help treat trichotillomania.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Folliculitis decalvans and tufted folliculitis are related, and a new treatment with rifampicin and clindamycin is effective.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

The treatment improved facial structure and corrected bite issues in patients.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Baricitinib is safer than methotrexate for treating severe alopecia areata.

A new combination of tadalafil and finasteride improves drug performance and stability.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.